
|Videos|April 8, 2022
Residual Cardiovascular Risk
Ian Riddock, MD, describes residual cardiovascular risk, both with and without the use of statin therapies.
Advertisement
Episodes in this series

Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
















































